Abstract
Background
Diabetes mellitus is a serious public health problem, and its prevalence is increasing globally. However, there are scanty reports of the scope and burden of the disease among suburban populations of Nigeria. This study aims to determine the prevalence of diabetes mellitus and to determine the associated risk factors of the disease among the suburban population of Northern Nigeria.
Methodology
A community-based descriptive cross-sectional study was conducted in which 1100 subjects were recruited using a multistage random cluster sampling technique. They were screened for diabetes by fasting plasma glucose (FPG) or casual plasma glucose (CPG) estimation. Individuals with FOG >7mmol//l or CPG >7.8mmol/l abnormal glucose levels had a 75 g oral glucose tolerance test (OGTT) and HbA1c done. The prevalence of diabetes was computed with a 95% confidence interval.
Result
The crude prevalence of diabetes from this study is 4.1% (95% CI = 3.3 – 4.9%) and standardized rate of 6.4%. Male gender OR 0.74, (95% CI = 0.569 – 1.982), age >40yrs OR 1.12 (95% CI = 0.851 – 1.463), physical inactivity OR 3.78 (95% CI = 2.881 - 12.726), Hypertension (SBP OR 10.28 (95% CI = 6.319– 29.369), (DBP OR 7.52 (95% CI = 3.928 – 36.914), and family history of DM OR 9.34 (95% CI = 3.890 – 23.481), showed significant independent association with diabetes.
Conclusion
The prevalence of diabetes in the suburban population of Northwestern Nigeria is high and the associated risk factors include overweight and obesity, physical inactivity, family history of diabetes and age.
Keywords: Prevalence, Diabetes mellitus, Risk factors, Suburban, Community Survey
Introduction
The prevalence of diabetes mellitus (DM) is increasing rapidly worldwide and is now recognized as a global public health problem. In addition, various complications of diabetes are at an epidemic level and thus have now become an important health-threatening condition[1]. Epidemiological evidence suggests that, without effective prevention and control programmes, the burden of diabetes will continue to increase globally. The International Diabetes Federation (IDF) estimated in 2017, that there are 451 million adults with diabetes globally and the figure was projected to rise to a 693million by 2045[2]. Of those expected to have diabetes, almost half are undiagnosed and living with the disease. These figures are expected to rise more in sub-Saharan Africa than in any part of the world[2].
The burden of DM in Sub-Saharan Africa and Nigeria is not fully known owing to the paucity of population-based studies[1], for instance, IDF estimates for the prevalence of diabetes in Nigeria has been fluctuating declining from 4.6% in 2014[3] to 3.1% in 2019. A recent meta-analysis on the prevalence of diabetes in Nigeria was reported as 5.77% by Uloko et al[4].
Nigeria's DM prevalence based on the 1997 National Expert Committee report on Non-communicable Disease (NCD) was 2.2% with a male: female ratio of 1.1:1, while the crude prevalence of DM in urban Kano was put at 1.8%[5]. Despite the lack of adequate data, studies have shown that diabetes is a major cause of morbidity and mortality among the adult population accounting for more than 40% of hospital admissions[6-8]. Several studies have demonstrated that the prevalence of diabetes mellitus in Nigeria has been increasing since the 1960s from 1% [9-11] to about 4% in the 2000s[3,11].
Strong evidence exists in the literature to suggest that interventions that prevent type 2 diabetes mellitus (T2DM) in individuals with dysglycaemia [Impaired glucose tolerance (IGT)) and impaired fasting glucose (IFG)] have been effective[12,13]. There is also evidence in the literature to support the screening of T2DM and IGT combined than screening for T2DM alone.
Several risks factors like Overweight, family history and sedentary lifestyle have been reported to be the most important risk factors for diabetes in Nigeria[3].
The two intermediate categories of glucose intolerance, IFG and IGT, have been shown in several studies to be strongly associated with cardiovascular disease risk;[13-15], Yet population-based studies on the prevalence and risk factors for diabetes, and other forms of glucose dysregulation in Nigeria is scanty. This paper seeks to provide some information on the prevalence of DM in Kano and Nigeria at large. It will help in planning intervention and prevention strategies that have been shown to work well in other countries.
Method
This was a descriptive cross-sectional community-based study that was conducted in the Kumb otso local Government area of Kano state Nigeria which is about 22km from Kano city. It has a total land area of 20,760sq kilometres and a population of 9,383,682 based on the official 2006 National Population and Housing Census and almost equal distribution of male (51%) and female (49%)with a predominant occupation of subsistence farming[16].
Ethical approval was obtained from Aminu Kano Teaching Hospital Kano and the Kano state ministry of health. Pregnant women, persons who are known to have diabetes mellitus, very ill persons and persons who declined consent were excluded from the study.
The sample size for the study was determined using the following formula was used: n= z2 pq /d2
Based on the prevalence of diabetes mellitus in a Nigerian urban city similar to Kano (Lagos mainland = 7.4%) as reported by the expert committee on non-communicable disease survey of 1997[5].
n=Minimum sample size
z = standard normal deviate at 95% confidence level = 1.96
p= prevalence of Diabetes mellitus obtained from previous study (7.4% = 0.074)
q= Complementary probability to p = 1-p = 1-0.074 = 0.0926
d= absolute precision limit required (2%) 0.02
Thus n= (1.96) 2 (0.074) (0.926)/ (0.02) 2 = 658 +10%
=658+68 = 718
1100 persons were recruited to accommodate non-responders.
Study Population
The Subjects included adult males and females aged 18years and above resident within the study area who meets the inclusion criteria were enrolled on the study.
Study Procedure
Permission and cooperation for the study were obtained from the village and ward heads of the respective communities.
Research assistants who speak English, as well as the local languages (Hausa), were recruited and trained to assist in data collection and anthropometric measurements.
An interviewer-administered questionnaire based on a modification of the WHO STEPS Instrument was used for data collection. Anthropometric measurements were carried out on each subject as follows;
Weight was measured to the nearest 0.1kg with subjects in light clothing and without shoes, while standing on a calibrated bathroom scale, positioned on a flat even surface[17]. Height was measured to the nearest 0.1cm using a height stand with subjects barefooted and without headgear while standing erect[17]. Body mass index (BMI) was calculated as weight in kg divided by the square of height in meters (m2) i.e. kg/m using the Quetelet formula BMI = weight (kg)/height (m)2, [17]Waist circumference (WC) was measured to the nearest 0.1cm using a non-stretchable dressmaker's tape at a point mid-way between the margin of the lowest rib and the iliac crest in the horizontal level. This was done with the subject standing erect at an expiratory phase of respiration[17] Hip circumference (HC) was measured to the nearest 0.1cm at the horizontal level of the maximum circumference around the gluteal region (posteriorly) and the pubic symphysis (anteriorly) with the tape parallel to the floor. This was done with the subject standing erect at the end of a normal expiration16 Waist to hip ratio (WHR) was calculated as the waist circumference in centimetre (cm) divided by hip circumference in centimetre (cm)[17].
Biochemical Measurement.
After 10-12 hours of overnight fast, venous samples were collected from the subjects. The blood samples were immediately centrifuged and separated. The sera were analyzed for glucose, lipids and fasting plasma insulin. Subjects who had fasting plasma glucose in the pre-diabetes range had OGTT done.
Serum Glucose was determined using the glucose oxidase method of Trinder. Total Cholesterol; this was determined using the cholesterol oxidase and cholesterol ester method. High-Density Lipoprotein (HDL) was estimated by the precipitation method. Triglyceride was determined using the lipoprotein lipase enzymatic procedure. Glycated Hemoglobin was measured using the HPLC technique with Bio-Rad 10 analyzer.
Ethical Clearance and Ethical consideration
Approval was sought for and obtained from the AKTH Ethical Committee (Ref No. NHREC/21/08/2008/AKTH/EC/1105). Informed consent was also obtained from all the participants before enlisting in the study. Participants that were found to be diabetic or had abnormal blood glucose were counselled and referred to a health facility of their choice for further management after the study. Ethical considerations were observed following the provisions of the Helsinki declaration on research in human subjects.
Statistical Methods
Data were was analyzed using SPSS version 16.0. P values <0.05 were considered statistically significant. The validity (specificity sensitivity, positive predictive values, negative predictive values, likelihood ratios and accuracy) of HbA1C, FPG, and 2-hour PG load was determined. In all statistical comparisons, a p-value of ≤0.05 was considered to be statistically significant.
Results
One thousand one hundred (1100) subjects were recruited into the study, 1024 subjects completed the study, giving a response rate of 93.1 %. Of those who completed the study, there were 419 (40.9%) males and 605 (59.1%) females giving a sex ratio of 1:1.5 in favour of females.
The mean ±SD age of the subjects was 41.9±17.6 years, with a range of 18 – 94 years. The mean ±SD age of the females and males was 43.4±18.7 and 39.7±16.2 respectively, with the latter being younger. The majority of the subjects were in their second and third decade of life. The distribution of the study subjects by age and gender is as shown in table 1.
Table 1:
Sociodemographic variables
| Socio-Demographic Variable | Total | |
|---|---|---|
| N | Frequency | |
| Age (Years) | (%) | |
| <20 | 48 | 4.69 |
| 20-29 | 227 | 22.17 |
| 30-39 | 237 | 23.14 |
| 40-49 | 152 | 14.84 |
| 50-59 | 162 | 15.82 |
| 60-69 | 82 | 8.01 |
| 70-79 | 61 | 5.96 |
| ≥80 | 55 | 5.37 |
| - | 1024 | 100.00 |
| Educational Status | ||
| Quranic Education | 109 | 24.60 |
| Primary Education | 221 | 49.89 |
| Secondary Education | 104 | 23.48 |
| Others | 8 | 1.81 |
| Tertiary | 1 | 0.23 |
| Total | 443 | 100.00 |
| Marital Status | ||
| Single | 171 | 16.70 |
| Married | 774 | 75.59 |
| Separated | 74 | 7.23 |
| Widowed | 5 | 0.49 |
| Total | 1024 | 100.00 |
| Occupation | ||
| Unemployed | 171 | 16.70 |
| Business | 575 | 56.15 |
| Housewife | 193 | 18.85 |
| Teaching | 11 | 1.07 |
| Farming | 74 | 7.23 |
| Total | 1024 | 100.00 |
The mean ±SD BMI of the study subjects was 23.3 ±SD 4.6 Kg/m2 and in males and females was 22.7 ±3.7 Kg/m2 23.7 ± 5.1 Kg/m2 respectively in females (p=0.001), while mean±SD WHR of male subjects was 0.9 ± 0.6 and that of the females was 0.9± 0.7. Table 2.
Table 2:
Prevalence and variables in the study population
| Variable | Male (n=419) | Female (n=605) | P-Value | Sample Population |
|---|---|---|---|---|
| Age (years), mean ± SD | 43.4±18.7 | 39.7±16.2 | <0.001 | 41.9+17.16 |
| BMI (Kg/M2), mean ± SD | 22.7±3.7 | 23.7±5.1 | <0.001 | 23.3±4.6 |
| WHR, mean 1 SD | 0.9±0.6 | 0.9±0.7 | <0.001 | 0.9±0.6 |
| FPG (mmol/1) mean, ± SD | 5.1±0.3 | 4.5±0.2 | <0.001 | 4.7±0.2 |
| CPG (mmol/1) mean, ± SD | 6.5±0.6 | 6.1+0.7 | <0.01 | 6.2±0.8 |
| HbAlc (%) mean, ± SD | 6.0±0.5 | 4.9±0.4 | <0.001 | 5.3±0.3 |
| FPI (ui/1) mean, ± SD | 6.0±0.4 | 4.8±0.5 | <0.001 | 5.5±0.4 |
| Crude prevalence of DM (%) | 6.2 | 2.6 | - | 4.1 |
| Standardized Prevalence (%) | 5.2 (4.1 - 5.9) | 2.8 (1.8 - 3.2) | - | 6.4 |
| Undiscovered DM (%) | 3.3 | 2.1 | - | 2.6 |
*= Significant p ≤0.05
The crude prevalence of diabetes from this study is 4.1% (95% CI = 3.3 – 4.9%) and standardized rate of 6.4%, and 27 patients (2.6%) were undiagnosed to have DM. Table 2 and 3. Male gender, diastolic blood pressure, systolic blood pressure, age >40, physical inactivity and family history of diabetes showed a significant independent association with diabetes. Table 4. The prevalence of dysglycaemia in this study was 4.3% for IFG, 1.91% for IGT
Table 3:
Modifiable Risk Factors for Diabetes Mellitus in the study population
| Risk Factor | Diabetes | ||||
|---|---|---|---|---|---|
| Yes(42) | No (982) | P-Value | |||
| BMI (Kg/M2) | |||||
| <25 | 15 | 860 | <0.0001* | ||
| ≥25 | 27 | 122 | |||
| WHR | |||||
| <0.85 | 29 | 112 | <0.0001* | ||
| ≥0.85 | 13 | 870 | |||
| Physical Activity | |||||
| Active | 18 | 114 | <0.0001* | ||
| Not active | 24 | 868 | |||
| Alcohol | |||||
| <21 units/week | 2 | 192 | 0.238 | ||
| ≥21units/week | - | 830 | |||
| Cigarette smoking | |||||
| Yes | 2 | 9 | <0.0001* | ||
| No | - | 1013 | |||
| Frequent fruits and vegetables | |||||
| >5 days per week | 31 | 98 | 0.0031* | ||
| ≥5 days per week | 11 | 884 | |||
| SBP | |||||
| Hypertensive | 25 | 337 | <0.0001* | ||
| Normotensive | 17 | 645 | |||
| DBP | |||||
| Hypertensive | 26 | 329 | <0.0001* | ||
| Normotensive | 16 | 653 | |||
*= Significant p ≤0.05; BMI= Body Mass Index; WHR= Waist – Hip ratio; SBP = Systolic Blood pressure; DBP= Diastolic Blood Pressure.
Table 4:
Non-modifiable risk factors for Diabetes Mellitus in the study population
| Risk Factor | Diabetes | |||
|---|---|---|---|---|
| Yes(42) | No (982) | P-Value | ||
| Age | ||||
| <40 | 10 | 502 | <0.0001* | |
| ≥40 | 32 | 482 | ||
| Gender | ||||
| Male | 26 | 393 | <0.0001* | |
| Female | 16 | 589 | ||
| Diabetes in first-degree relatives | ||||
| Yes | 7 | 61 | <0.0001* | |
| No | 35 | 921 | ||
| Social Class | ||||
| Upper | 16 | 611 | <0.01 | |
| Middle | 18 | 342 | ||
| Lower | 8 | 71 | ||
*= Significant p ≤ 0.0;5
Male gender OR 0.74, (95% CI = 0.569 – 1.982), age >40yrs OR 1.12 (95% CI = 0.851 – 1.463), physical inactivity OR 3.78 (95% CI = 2.881 - 12.726), Hypertension (SBP OR 10.28 (95% CI = 6.319– 29.369), (DBP OR 7.52 (95% CI = 3.928 – 36.914), and family history of DM OR 9.34 (95% CI = 3.890 – 23.481), showed significant independent association with diabetes.
Figure 1:

A flow chart showing subjects enrolment
Figure 2:
Flow Chart of Subjects showing the schema for validity calculation.
Abbreviations: FPG= Fasting Plasma Glucose; RPG=Random Plasma Glucose; OGTT=Oral Glucose Tolerance Test; IGT=Impaired Glucose Tolerance; DM= Diabetes Mellitus; HbA1c= Haemoglobin A1c.
Foot Notes: Test A- OGTT, Test B- HbA1c
Table 5:
Logistic regression analysis Risk factors for Diabetes Mellitus in the study population
| Risk factor | p-Value | Odds ratio | 95% Confidence Interval |
|---|---|---|---|
| Age | 0.004 | 1.12 | 0.851-1.463 |
| Gender (Male) | 0.000 | 0.74 | 0.569 -1.982 |
| WHR | 0.000 | 3.53 | 1.932 - 8.325 |
| BMI (Obese and Overweight) | 0.002 | 4.26 | 1.872-6.182 |
| Family History of Diabetes | 0.000 | 9.34 | 3.890 - 23.481 |
| Physical In Activity | 0.098 | 3.78 | 2.881 - 12.726 |
| SBP | 0.000 | 10.28 | 6.319-29.369 |
| DBP | 0.000 | 7.52 | 3.928 - 36.914 |
| Fruit Intake | 0.003 | 1.79 | 0.993 -12.372 |
| Tobacco use | 0.438 | 0.19 | 0.30-0.836 |
| Alcohol Use | 0.389 | 0.27 | 0.40-0.991 |
*= Significant p ≥ 0.0;5BMI= Body Mass Index; WHR= Waist — Hip ratio; SBP = Systolic Blood pressure; DBP= Diastolic Blood Pressare.
Table 6:
Prevalence of Dysglycaemia Diabetes Mellitus in the study
| Parameter | DM | IFG | IGT | Undiagnosed DM |
|---|---|---|---|---|
| n | 42 | 44 | 20 | 27 |
| % | 4.1% | 4.3 | 1.9 | 2.8 |
Diabetes Mellitus; IFG= Impaired Fasting Glycaemia; IGT= Impaired Glucose Tolerance;
Discussion
This study was conducted to determine the prevalence of undiagnosed diabetes mellitus and its associated risk factors. It represents a survey of a Sub-urban population of the Northwestern part of Nigeria.
From this study, the crude prevalence of diabetes was 4.1%, in the general population and 6.2% and 2.4%, and males and females respectively. The rate obtained from this study is similar to that reported from metanalysis Adeloye et al[18], and other studies from other parts of the country by (4.0%)[19], 4.06% by Chuwark[20] in Jos,[21] (4.3%), in Sokoto and (4.7%) in Okeogun in Nigeria[22]. Elsewhere in Mexico and the United States[23] in-Prima Indians 4.7%.It is however lower than the 2.2% reported from the NCD national survey by Akinkugbe[24] NCD and 2.2% reported by Olatobosunin Ibadan. The WHO estimates for the prevalence of diabetes in Nigeria was 4.3%[15,25,26]. Higher rates have been reported from Calabar (7.0%)[3], Nyenwe et al[23] (6.8%), in Port Harcourt Nigeria. This difference may be accounted for by the higher socioeconomic status of people of the oil-rich Niger Delta region of Nigeria, a systematic review and meta-analysis by Uloko et al[27] put Nigeria's DM prevalence at 5.77%. Among hospital patients in Addis Ababa, 14.8% was reported[10].
Undiagnosed diabetes in the study was 2.6%, similar to 2.8% reported by Nyenwe et al in Port Harcourt[28], but much higher than 1.7% reported by Owovhoriole[29] in urban Lagos in 1988.Comparison between studies is, of course, fraught with difficulties due to differences in the methodology for testing for glucose, diagnostic criteria and selection criteria which may differ substantially. The high prevalence of DM in this study may due to demographic transition and rapid urbanization.
Females constituted a larger proportion of the study participants. This was probably because the males were at their various places of work mostly in the farms, business premises or industries when the research team arrived and the women were more willing to participate in the study. In addition, most of the women are housewives and are therefore always at home[30,31]. This finding is similar to what has been reported by other scholars. In this study, the prevalence of DM is higher in males than females although gender differences in the prevalence of DM have been variably reported in the literature[30-32],[33,34]. Some others showed no gender difference[35-37].
Age is recognized as an independent risk factor for DM. In our study, DM was commoner among the middle-aged group with a steady increase with increasing age like in other studies[30,31]. The implication of this is that the bulk of our economic workforce or the economically active segment is the most affected by the disease. It, therefore, has a far-reaching socioeconomic implication in the sense that the economically viable part of society is the most affected. This is similar to reported figures from studies done in other parts of the country[9,29,30,368]. Therefore, employing aggressive measures to prevent the development of the disease will have a positive impact on the economy.
Family history of diabetes is a strong predictor of DM in this study. The is sufficient literature to show that family history of DM is a strong risk factor for DM. This finding has been corroborated in previous studies[19,30,39-41]. There are however a few studies that didn't show any risk of developing DM with a positive family history of DM in first degree relatives. Strong Family history of type 2 DM among first-degree relatives have been demonstrated by Cederbeg et al to be associated with both increased risk of becoming overweight/obese and greater susceptibility to increasing body fat, probably as a consequence of an increased propensity to accumulate non- subcutaneous fat[42]. Several genes have been identified that confer susceptibility to the development of DM first- and second-degree relatives[42,43].
Modifiable risk factors for DM like lack of physical activity, overweight and obesity have been found in this study similar to that reported in the literature to be associated with a higher prevalence of the disease[28-31]. The prevalence of diabetes in this study was noted to be higher among individuals with higher BMI (overweight and obese) as compared to those with normal weight among individuals with a lack of physical activity. Several studies across the country have reported a higher prevalence of obesity among subjects with type 2 DM in Nigeria[44] [45] and other countries[45]. Weight loss has been one of the targets of diabetes prevention programs that seek to reduce the risk of the development of diabetes in populations. Lifestyle measures have been implemented in various clinical trials and have been shown to prevent diabetes and even enhance the remission of DM in the various population studied.[13,46] Strategies helping patients lose weight, increase moderate-intensity physical activity levels to at least 150 min/wk., and increase fibre intake has worked well in the prevention of DM[25,26,47]. Calorie restriction for instance in the Direct trial has shown that 46% of participants were in remission toa non-diabetic state after one year and off antidiabetic drugs. A year later, 70% of those participants are still in remission[13,46].
The link between physical inactivity, overweight and obesity is an established risk factor for type 2 DM, may be related to increased pro-inflammatory cytokines (tumour necrosis factor and interleukin-6), insulin resistance, deranged fatty acid metabolism, and cellular processes such as mitochondrial dysfunction and endoplasmic reticulum stress[41,48]. It is, therefor e important, to prevent and control obesity in the population, as one of the modifiable risk factors for the development of diabetes, doing this will help the efforts to reduce the risk of development of T2DM. In addition to the effect of exercise on weight loss, it may also help to enhance glucose uptake in tissues through several mechanisms like increasing insulin sensitivity, through an increase in GLUT-4 receptors in the cell membrane, enhancing insulin signaling in tissues, and increasing the utilization of glucose in exercising tissues[13,46]. Given the epidemic of obesity and type 2 diabetes globally, the benefits of exercise and increased physical activity on carbohydrate metabolism underscore its importance in preventing diabetes[13,46].
Conclusion
The crude prevalence of diabetes mellitus in this study was found to be 4.1% using the WHO 1999 criteria and 4.9 % when adjusted for age and gender. Increasing Age, familial history of diabetes, and obesity are the main risk factors associated with the development of diabetes mellitus.
Limitations of this study
One of the limitations of this study like other epidemiological studies is its cross-sectional design which makes it impossible to identify the association between diabetes and other cardiovascular risk factors. Secondly, OGTT could not be done for the entire population.
Acknowledgment
The authors acknowledged the efforts of Musa Rufai Kumbotso and other staff of the Kumbotso Primary Health Care Centre and the Comprehensive Medical Centre.
Ethical Approval and consent
Ethical clearance was obtained from the Aminu Kano Teaching Hospital and the Kano State Ministry of Health. Written informed consent was obtained from all the participants who participated in the study. All copies of the written consent and ethical clearance are available for review by the Editor-in-Chief of this journal.
Declaration
The authors have no conflicts of interest to declare.
Funding
The study was self-funded. There was no external source of funding.
Author Contributions
MAR, RAH and MB wrote the manuscript, AEU, MAR and IDG edited the manuscript, RAH, and AUA edited and reviewed the manuscript. All authors contributed equally to the preparation of the paper.
Consent for publication
All the authors have agreed to consent to the publication of the article in this journal.
Abbreviations
CPG= Casual plasma glucose; DM= Diabetes Mellitus; FPG= Fasting Plasma Glucose; HbA1c= Haemoglobin A1c.; IGT=Impaired Glucose Tolerance; OGTT=Oral Glucose Tolerance; RPG =Random Plasma Glucose; Test; Type 2 diabetes Mellitus = T2DM
References
- 1.Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF, Sobngwi E1, Mauvais-Jarvis F, Vexiau P, Mbanya JC GJF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27:628-34. https://doi.org/MDOI-DM-12-2001-27-6-1262-3636-101019-ART50 [pii]. [PubMed] [Google Scholar]
- 2.IDF. IDF diabetes atlas regional factsheet 9th edition 2019; 2019:1-14. [Google Scholar]
- 3.Uloko AE, Musa BM, Ramalan MA, Gezawa ID, Puepet FH, Uloko AT, et al. Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Therapy 2018; 9:1307-16. 10.1007/s13300-018-0441-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Adeloye D, Ige JO, Aderemi A v, Adeleye N, Amoo EO, Auta A, et al. Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ Open 2017;7. 10.1136/bmjopen-2016-015424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Akinkugbe OO. The National Expert Committee on Non-communicable Diseases in Nigeria, Final report on non-communicable disease survey 1997. 1997.
- 6.Omenai S, Ezenkwa U, Ajani M. Mortality patterns in patients with diabetes mellitus at a Nigerian tertiary hospital: A 10-Year autopsy study. Nigerian Postgraduate Medical Journal 2020;27. 10.4103/npmj.npmj_160_19. [DOI] [PubMed] [Google Scholar]
- 7.Fasanmade OA, Dagogo-Jack S. Diabetes Care in Nigeria. Annals of Global Health 2016;81. 10.1016/j.aogh.2015.12.012. [DOI] [PubMed] [Google Scholar]
- 8.Oguejiofor O. Diabetes in Nigeria: Impact, Challenges, Future Directions. Endocrinology & Metabolic Syndrome 2014;03. 10.4172/2161-1017.1000130. [DOI]
- 9.Osuntokun BO AFFTRSOOTGO. Diabetes mellitus in Nigerians: a study of 832 patients. West Afr Med J Niger Pract 1971; 20:295-312. [PubMed] [Google Scholar]
- 10.Ohwovoriole AE, Kuti JA, Kabiawu SIO. Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos Metropolis Nigerians. Diabetes Research and Clinical Practice 1988;4. 10.1016/S0168-8227(88)80010-X. [DOI] [PubMed]
- 11.da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Research and Clinical Practice 2016;117. 10.1016/j.diabres.2016.04.016. [DOI] [PubMed] [Google Scholar]
- 12.Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males. Diabetes Research and Clinical Practice 2005; 67:152-62. 10.1016/j.diabres.2004.06.010. [DOI] [PubMed] [Google Scholar]
- 13.Adeleke OR, Ayenigbara GO. Preventing Diabetes Mellitus in Nigeria: Effect of Physical Exercise, Appropriate Diet, and Lifestyle Modification. International Journal of Diabetes and Metabolism 2019;25. 10.1159/000502006. [DOI] [Google Scholar]
- 14.Galaviz KI, Narayan KMV, Lobelo F, Weber MB. Lifestyle and the Prevention of Type 2 Diabetes: A Status Report. American Journal of Lifestyle Medicine 2018;12. 10.1177/1559827615619159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Roumen C, Blaak EE, Corpeleijn E. Lifestyle intervention for prevention of diabetes: determinants of success for future implementation. Nutrition Reviews 2009; 67. 10.1111/j.1753-4887.2009.00181.x. [DOI] [PubMed] [Google Scholar]
- 16.The Federal Republic of Nigeria. Legal notice on publication of 2006 census final results. vol. 96. 2009. [Google Scholar]
- 17.Gadzik J. "How much should I weigh?" --Quetelet's equation, upper weight limits, and BMI prime. Conn Med 2006; 70:81-8. [PubMed] [Google Scholar]
- 18.Sabir A, Balarabe S, Sani A, Isezuo S, Bello K, Jimoh A, et al. Prevalence of diabetes mellitus and its risk factors among the suburban population of Northwest Nigeria. Sahel Medical Journal 2017; 20. 10.4103/smj.smj_47_16. [DOI] [Google Scholar]
- 19.Rasaki SO, Kasali FO, Biliaminu SA, Odeigah LO, Sunday AA, Sule AG, et al. Prevalence of diabetes and pre-diabetes in Oke-Ogun region of Oyo State, Nigeria. Cogent Medicine 2017; 4:1-7. 10.1080/2331205x.2017.1326211. [DOI] [Google Scholar]
- 20.Schulz LO, Bennett PH, Ravussin E, Kidd JR, Kidd KK, Esparza J, et al. Effects of Traditional and Western Environments on Prevalence of Type 2 Diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 2006;29. 10.2337/dc06-0138. [DOI] [PubMed] [Google Scholar]
- 21.Akinkugbe OO. The National Expert Committee on Non-communicable Diseases in Nigeria, Final report on non-communicable disease survey 1997. 1997. [Google Scholar]
- 22.Enang OE, Otu AA, Essien OE, Okpara H, Fasanmade OA, Ohwovoriole AE, et al. Prevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, Nigeria. BMJ Open Diabetes Research & Care 2014;2: e000032. 10.1136/bmjdrc-2014-000032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: A study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Research and Clinical Practice 2003;62:177-85. 10.1016/j.diabres.2003.07.002. [DOI] [PubMed] [Google Scholar]
- 24.Sahile AT, Bekele GE. <p>Prevalence of Diabetes Mellitus and Associated Factors in Addis Ababa Public Health Facilities, Addis Ababa, Ethiopia, 2016</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020;13. 10.2147/DMSO.S237995. [DOI] [PMC free article] [PubMed]
- 25.Tataranni PA, Bogardus C. Changing Habits to Delay Diabetes. New England Journal of Medicine 2001; 344:1390-2. 10.1056/nejm200105033441809. [DOI] [PubMed] [Google Scholar]
- 26.Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine 2001;344. 10.1056/NEJM200105033441801. [DOI] [PubMed] [Google Scholar]
- 27.nga_en n.d.
- 28.Fadupin GT, Joseph EU, Keshinro O.O. Prevalence of obesity among type 2 diabetics in Nigeria a case study of patients in Ibadan, Oyo State, Nigeria. African Journal of Medicine and Medical Sciences 2004; 33:381-384. [PubMed] [Google Scholar]
- 29.Damian DJ, Kimaro K, Mselle G, Kaaya R, Lyaruu I. Prevalence of overweight and obesity among type 2 diabetic patients attending diabetes clinics in northern Tanzania. BMC Research Notes 2017;10. 10.1186/s13104-017-2861-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ibrahim H, Puepet F, Muazu S, Mubi B, Gezawa I, Mustapha S, et al. Prevalence and risk factors for impaired glucose regulation among first-degree relatives of patients with type 2 diabetes mellitus in Maiduguri, Northeastern Nigeria. Journal of Diabetology 2020;11. 10.4103/jod.jod_5_19. [DOI] [Google Scholar]
- 31.Ejim EC, Okafor CI, Emehel A, Mbah AU, Onyia U, Egwuonwu T, et al. Prevalence of Cardiovascular Risk Factors in the Middle-Aged and Elderly Population of a Nigerian Rural Community. Journal of Tropical Medicine 2011;2011. 10.1155/2011/308687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Seck SM, Dia DG, Doupa D, Diop-Dia A, Thiam I, Ndong M, et al. Diabetes Burden in Urban and Rural Senegalese Populations: A Cross-Sectional Study in 2012. International Journal of Endocrinology 2015;2015. 10.1155/2015/163641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Peer N, Steyn K, Lombard C, Lambert E v., Vythilingum B, Levitt NS. Rising Diabetes Prevalence among urban-dwelling Black South Africans. PLoS ONE 2012;7. 10.1371/journal.pone.0043336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Duboz P, Chapuis-Lucciani N, Boëtsch G, Gueye L. Prevalence of diabetes and associated risk factors in a Senegalese urban (Dakar) population. Diabetes & Metabolism 2012;38. 10.1016/j.diabet.2012.02.011. [DOI] [PubMed] [Google Scholar]
- 35.Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. Journal of Internal Medicine 1998;244. 10.1046/j.1365-2796.1998.00369.x. [DOI] [PubMed] [Google Scholar]
- 36.Peters SAE, Woodward M. Sex Differences in the Burden and Complications of Diabetes. Current Diabetes Reports 2018;18. 10.1007/s11892-018-1005-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Zhang H, Ni J, Yu C, Wu Y, Li J, Liu J, et al. Sex-Based Differences in Diabetes Prevalence and Risk Factors: A Population-Based Cross-Sectional Study Among Low-Income Adults in China. Frontiers in Endocrinology 2019;10. 10.3389/fendo.2019.00658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Basukala A, Sharma M, Pandeya A. Prevalence of overweight and obesity among patients with type 2 diabetes mellitus in Kathmandu. Sky J Microbiol Res 2014; 3:60-4. [Google Scholar]
- 39.Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. Journal of Global Health 2018;8. 10.7189/jogh.08.010803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Agu U, Agu MC, Nnaji GA. Assessment of risk of developing diabetes mellitus among local government employees in Onitsha, south-eastern Nigeria. Epidemiology Reports 2015;3. 10.7243/2054-9911-3-4. [DOI] [Google Scholar]
- 41.Chakraborti CK. Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity. World Journal of Diabetes 2015;6. 10.4239/wjd.v6.i15.1296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cederberg H, Stan?áková A, Kuusisto J, Laakso M, Smith U. Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? Journal of Internal Medicine 2015;277. 10.1111/joim.12289. [DOI] [PubMed] [Google Scholar]
- 43.Ali O. Genetics of type 2 diabetes. World Journal of Diabetes 2013;4. 10.4239/wjd.v4.i4.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Adebisi S, Oghagbon E. Prevalence of Obesity Among Diabetics in Ilorin, Middle Belt of Nigeria. Sahel Medical Journal 2004;6. 10.4314/smj2.v6i4.12853. [DOI] [Google Scholar]
- 45.Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet 2018; 391:541-51. 10.1016/S0140-6736(17)33102-1. [DOI] [PubMed] [Google Scholar]
- 46.Borghouts LB, Keizer HA. Exercise and Insulin Sensitivity: A Review. International Journal of Sports Medicine 2000;21. 10.1055/s-2000-8847. [DOI] [PubMed] [Google Scholar]
- 47.Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N. Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. the DE-PLAN study. Diabetic Medicine 2010; 27:459-65. 10.1111/j.1464-5491.2010.02918.x. [DOI] [PubMed] [Google Scholar]
- 48.Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized? The Journal of Clinical Endocrinology & Metabolism 2011;96. 10.1210/jc.2011-0585. [DOI] [PMC free article] [PubMed] [Google Scholar]
